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Marine Lenhart syndrome occurs rarely at any
age, we present a case of this unusual condition
occurring in an octogenarian.
Introduction
Thyroid dysfunction is relatively common, with
hypothyroidism in women reported to have a
prevalence of 4.1 per 1000 population, and 0.8
per 1000 having hyperthyroidism.
1 Unlike
hypothyroidism which becomes more prevalent
with age, Grave’s disease – autoimmune
hyperthyroidism – seems to not do this, with the
incidence remaining relatively steady at 1 in 1000
per year between the ages of 35 and 60 years.
1
Thyroid nodules are also very common, being
palpable in approximately 5%, and being detectable
on ultrasound in up to two thirds in the general
(iodine replete) population.
2 The prevalence has
been shown to be higher with increasing age and
in women.
3 The vast majority of these nodules are
non-functioning, and cause no symptoms. Thus the
presence of autonomously functioning nodules
within a Grave’s thyroid is rare, occurring in 0.8% to
2.7% of cases of Grave’s disease.
4,5 We present such
a case of Marine Lenhart syndrome – functioning
nodules within an overactive thyroid gland – in a
lady of advanced age.
Case Report
An 81-year-old woman was admitted in January
2007 with worsening symptoms of heart failure.
She had a past history of mitral regurgitation due
to bi-leaﬂet mitral valve prolapse and had several
previous admissions due to heart failure. Her
medication list included calcium and vitamin D,
furosemide, ramipril, and warfarin. She was also
on sotalol which had been started 2 days prior to
admission by her general practitioner. On examin-
ation she was short of breath at rest and in atrial
ﬁbrillation with a fast ventricular rate. She also
had evidence of peripheral oedema, a raised
jugular pressure and lung crepitations. Palpation
of her thyroid gland was unremarkable.
Her blood tests showed that she was biochemi-
cally thyrotoxic with a thyroid stimulating
hormone (TSH) of 0.02 mIU/L (0.35–3.5), a free
thyroxine (fT4) of 24 pmol/L (8–21)andafree triio-
dothyronine (fT3) of 4.2 pmol/L (3.8–6.0). She was
started on carbimazole 20 mg twice daily by her
admitting team and her heart failure medication
was optimized. Over the following 5 days she
improved and was discharged with an endocrin-
ology outpatient appointment. When she was seen
3 months later, her TSH was 12.34, fT4 11. She
was advised to decrease her dose of carbimazole
to20 mgonce dailyandwasreferred forradioactive
iodine treatment. A CT scan of her neck was also
arranged because of a history of choking whilst
eating and a feeling of neck fullness. This showed
that she had retrosternal extension of her goitre on
the left, with no evidence of tracheal compression.
Six weeks later, 100 micrograms of thyroxine
was added as part of a block and replace regime
whilst waiting for her radioactive iodine and her
thyroid function test results to normalize with a
TSH of 0.6 and a fT4 of 22, a further 6 weeks later.
In our institution, a Tc-99m thyroid scan is per-
formed prior to the administration of radioactive
iodine. This showed 2 foci of decreased tracer
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1accumulation at either lower pole of the thyroid
with generalized intense tracer uptake within an
enlarged thyroid gland (Figure 1). This was
consistent with a diagnosis of Marine-Lenhart
syndrome on a background of Grave’s disease.
When last checked in November 2011, her
thyroid function tests were normal.
Discussion
Marine-Lenhart Syndrome was ﬁrst described in
1911.
6 The tissue within the functioning nodule
becomes suppressed by the overactivity of the
remaining gland and therefore does not take up
tracer or radioiodine. However, as the remainder
of the gland is treated with oral medication and
becomes progressively less active, the nodules
become more active.
There has been controversy regarding how to
diagnose Marine-Lenhart syndrome, depending on
whatimaging techniqueshavebeenusedtoidentify
thepresenceofathyroidnodule.Ifultrasoundscan-
ning has identiﬁed a nodule with no differences in
uptake on Tc-99m scanning, or if no ultrasound
scan is done, it is difﬁcult to justifythe diagnosis.
7,8,9
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Figure 1
There is intense tracer accumulation seen within an enlarged
thyroid gland. There are two foci of decreased tracer accumu-
lation at either lower pole consistent with Marine Lenhart
syndrome on a background of Graves.
J R Soc Med Sh Rep 2012;3:21. DOI 10.1258/shorts.2011.011164
Journal of the Royal Society of Medicine Short Reports
2